Immunohistochemical characterisation of the main histologic subtypes of epithelia renal tumors on tissue-microarrays.: A study of 310 cases

被引:19
作者
Bazille, C
Allory, Y
Molinié, V
Vieillefond, A
Cochand-Priollet, A
Cussenot, O
Callard, P
Sibony, M
机构
[1] Hop Tenon, Serv Anat Pathol, F-75020 Paris, France
[2] Hop Foch, Serv Anat Pathol, F-92151 Suresnes, France
[3] Hop Cochin, Serv Anat Pathol, F-75014 Paris, France
[4] Hop Lariboisiere, Serv Anat & Cytol Pathol, F-75745 Paris 10, France
[5] Hop Tenon, Serv Urol, F-75020 Paris, France
关键词
renal tumors; tissue; -microarrays; immununohistochemistry; CK7; Vimentin; CD10;
D O I
10.1016/S0242-6498(04)93995-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases Objective: Diagnosis of renal epithelial tumours of adult is often easily mode. Nevertheless, it can be difficult to distinguish clear cell carcinoma (CCC) and chromophobe carcinoma (CCHRO), or the eosinophilic variants of CCC and CCHRO with papillary carcinoma (CTP) and oncocytoma (ONCO). The objective is to study and validate immunohistochemical phenotypes of these tumours and to evaluate if they are helpful and to define a diagnostic strategy. Materials and methods: 310 tumours (75 CCC, 89 CTP, 50 CCHRO and 96 ONCO) were collected and put on 4 tissue-arrays blocks. Immunohis tochimical stainings were performed with some usual antibodies: poncytokeratin AEI-AE3, EMA, vimentin, CD10, CK7, CK20 and RCC (Renal Cell Corcinoma). Results: Poncytokeratin AEI-AE3 is expressed mainly in CTP (82.5%). The cytoplasmic staining of EMA is seen in almost all CCHRO (98%) and more than half of CTP (57%). Vimentin is rather specific of CCC (54.5%) and CTP(85%) whereas it is negative in ONCO and CCHRO. CD10 is expressed in the majority of CCC (86.5%) and in some of CTP and CCHRO 65 and 39% respectively. CK7 is rather specific of CTP and CCHRO with 79 and 81.5% of positivity rate. Based on statistical analysis, we have built a diagnostical tree allowing to distinguish 79% of tumours using only three antibodies: CK7, vimentin and CD10. Conclusion: CCG are CK7-/Vim-/CD10divided by or CK7-/Vimdivided by; CTP are CK7-/Vimdivided by; CCHRO are CK7+/Vim-; and ONCO CK7-/Vim-/CD10-. In the oncocytoma/chromophobe group, ONCO are more often CK7-/EMA- and CCHRO CK7divided by/ EMA+.
引用
收藏
页码:395 / 406
页数:12
相关论文
共 39 条
[11]   Tissue microarray technology for high-throughput molecular profiling of cancer [J].
Kallioniemi, OP ;
Wagner, U ;
Kononen, J ;
Sauter, G .
HUMAN MOLECULAR GENETICS, 2001, 10 (07) :657-662
[12]  
Khoury Joseph D, 2002, Ann Diagn Pathol, V6, P154, DOI 10.1053/adpa.2002.33901
[13]   Immunohistochemical profile of common epithelial neoplasms arising in the kidney [J].
Kim, MK ;
Kim, S .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (04) :332-338
[14]   Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[15]   Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma [J].
Leroy, X ;
Moukassa, D ;
Copin, MC ;
Saint, F ;
Mazeman, E ;
Gosselin, B .
EUROPEAN UROLOGY, 2000, 37 (04) :484-487
[16]   Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays [J].
Liu, CL ;
Prapong, W ;
Natkunam, Y ;
Alizadeh, A ;
Montgomery, K ;
Gilks, CB ;
van de Rijn, M .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) :1557-1565
[17]   Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome - The Prostate Specialized Program of Research Excellence Model [J].
Manley, S ;
Mucci, NR ;
De Marzo, AM ;
Rubin, MA .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (03) :837-843
[18]   Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma [J].
Mathers, ME ;
Pollock, AM ;
Marsh, C ;
O'Donnell, M .
HISTOPATHOLOGY, 2002, 40 (06) :563-567
[19]   Diagnosing primary and metastatic renal cell carcinoma - The use of the monoclonal antibody 'renal cell carcinoma marker' [J].
McGregor, DK ;
Khurana, KK ;
Cao, C ;
Tsao, CC ;
Ayala, G ;
Krishnan, B ;
Ro, JY ;
Lechago, J ;
Truong, LD .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (12) :1485-1492
[20]   High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma [J].
Moch, H ;
Schraml, P ;
Bubendorf, L ;
Mirlacher, M ;
Kononen, J ;
Gasser, T ;
Mihatsch, MJ ;
Kallioniemi, OP ;
Sauter, G .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) :981-986